Join to View Full Profile
9609 Medical Center DrRoom 5w426Bethesda, MD 20892
Phone+1 240-276-6093
Fax+1 240-276-7892
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 10 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Richard Little, MD is an oncologist in Bethesda, Maryland. He is currently licensed to practice medicine in Virginia.
Education & Training
University of South Carolina School of MedicineClass of 1989, MD
Certifications & Licensure
VA State Medical License 1992 - 2026
Publications & Presentations
PubMed
- Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B...Charalambos Andreadis, Olivia Bobek, Eric D Hsi, Timothy S Fenske, Patrick J Stiff
Leukemia & Lymphoma. 2025-07-09 - Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials.Anna Moseley, Michael LeBlanc, Boris Freidlin, Rory M Shallis, Amer M Zeidan
Clinical Trials. 2025-06-01 - Concordance between tumor tissue and plasma DNA genotyping in the NCI-MATCH trial (EAY131).Mohamed A Gouda, Filip Janku, Ying Yuan, Leylah M Drusbosky, Alice P Chen
Clinical Cancer Research. 2025-05-19
Authored Content
- Final Results of a Randomized Multicenter Phase II Study of Alvocidib, Cytarabine, and Mitoxantrone Versus Cytarabine and Daunorubicin (7+3) in Newly Diagnosed High-Risk Acute Myeloid Leukemia (AML)August 2018
Press Mentions
NCI’s myeloMATCH Precision Medicine Initiative Pushes the Envelope in Myeloid Leukemia CareJanuary 3rd, 2025- NIH Launches Precision Medicine Trial for Myeloid CancersOctober 24th, 2024
- NIH Launches myeloMATCH Precision Medicine Trials for Myeloid CancersOctober 23rd, 2024
- Join now to see all
